Leading myeloma specialists in Israel include Dr. Hila Magen and Dr. Abraham Avigdor at Sheba Medical Center, and Dr. Ron Ram at Sourasky Medical Center. These experts emphasize advanced cellular therapies like CAR-T and complex stem cell transplantation to treat relapsed or high-risk cases.
- Dr. Hila Magen. Leads Sheba's Myeloma Unit, specializing in CAR-T and amyloidosis for complex plasma disorders.
- Dr. Abraham Avigdor. Directs Sheba's Institute of Hematology with 35+ years experience in bone marrow transplantation.
- Dr. Ron Ram. Board-certified specialist at Sourasky Medical Center who performs hundreds of stem cell transplants.
- Prof. Dina Ben-yehuda. Head of Hematology at Hadassah Medical Center, specializing in molecular diagnostics and genetics.
Bookimed Expert Insight: While many specialists treat blood cancers, choosing a director of a specific myeloma or transplant unit often provides faster access to clinical trials. For example, Dr. Hila Magen acts as a principal investigator for innovative CAR-T programs, which can offer treatment paths not available at smaller oncology centers.
Patient Consensus: Patients often feel more secure in major units like those at Sheba or Sourasky because the departments work as a cohesive team. Experience bears out that having a specialist who can quickly determine transplant eligibility makes a significant difference in the treatment journey.
